• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches  
Title Created Date
[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial 24 April 2015
hSSTR2 expression and octreotide treatment reverses multidrug resistance of BxPC-3 human pancreatic cancer cells 23 April 2015
Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells 23 April 2015
Melatonin prevents the development of hyperplastic urothelium induced by repeated doses of cyclophosphamide 20 April 2015
Long-term treatment with bromocriptine inhibits endometrial adenocarcinoma development in rats 20 April 2015
Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1 17 April 2015
Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy 17 April 2015
Neuroprotection by melatonin on astrocytoma cell death 15 April 2015
Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer 15 April 2015
Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins 15 April 2015
Display # 

Page 75 of 111

  • Start
  • Prev
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin and its ubiquitous anticancer effects
  • Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus
  • Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
  • Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
  • High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
  • The impact of vitamin D on cancer: A mini review
  • Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
  • An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
  • Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
  • Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
  • Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
  • Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • How effective is chemo therapy?
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Vademecum
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer